SAN DIEGO, May 22, 2015 (GLOBE NEWSWIRE) — Medical Marijuana, Inc. (OTC Pink:MJNA), a leading cannabis and industrial hemp industry innovator, applauds the historic decision by the U.S. Senate Appropriations Committee<\/a> to provide Veterans access to medical cannabis in legalized states.<\/p>\n “While the majority of MJNA’s portfolio companies focus on industrial hemp, all have received inquiries from Veterans asking about cannabis product use in their state of residence,” states Stuart W. Titus, PhD and Chief Executive Officer of Medical Marijuana, Inc. “The historic decision by the Senate Appropriations Committee granting Veterans access to medical marijuana allows MJNA’s portfolio companies to serve the Veterans community \u2013 without question \u2013 in states with cannabis laws.”<\/p>\n Industrial hemp and marijuana are both in the cannabis genus. The difference between the two plants are the levels of naturally occurring cannabinoids. Marijuana is cultivated for an abundant amount of the cannabinoid THC. Quite the opposite in industrial hemp, THC is virtually non-existent and, therefore, cannot produce a psychotropic effect as its cousin plant can. This distinction has been noted as “low THC cannabis” in recent news. When it comes to legalized cannabis use, there are 39 states, districts and territories with cannabis laws on the books: 25 with medical or recreational marijuana<\/a> plus 14 states with “low THC cannabis.”<\/p>\n Dr. Titus continues, “We are thrilled by the Federal government’s support of the brave men and women of our armed forces who risk everything for our national security. Now it is our turn to serve these honorable Veterans.”<\/p>\n “Each of Medical Marijuana, Inc.’s companies is focused on growth in the emerging global cannabis market. By doing so, we will provide new employment opportunities in a wide range of skillsets. MJNA, our investments and subsidiary companies are on a mission to revitalize the industrial hemp industry in the USA. We encourage the Veterans community to learn more about this country’s hemp history and our initiatives. If interested, contact us as the industrial hemp industry may prove to be an avenue for future employment or entrepreneurship,” states Dr. Titus.<\/p>\n Lone Star State’s Limited Bill<\/strong><\/p>\n Meanwhile, the Texas House gave final approval Tuesday to what the media’s calling a “limited” medical marijuana bill that would give residents access to CBD oil that only contains trace amounts of THC. The legislation now hits Texas Gov. Greg Abbott’s desk \u2013 a development that some experts are calling history.<\/p>\n The Republican hasn’t said whether he will sign the very high-profile measure.<\/p>\n “We applaud lawmakers in the Lone Star State for taking action, it’s a step in the right direction, and we’re very excited to see even more progress,” Dr. Titus says.<\/p>\n Medical Marijuana, Inc.’s portfolio of investments and subsidiaries primarily focus on the manufacturing, marketing and distribution of industrial hemp products with open availability in all 50 states. MJNA’s industrial hemp investments, companies and brands include award-winning products.\u00a0The Company looks forward to updating the public and shareholders on many more advances in the cannabis industry in the weeks and months ahead. For more information on Medical Marijuana, Inc. and the portfolio company brands that it promotes, visit the Company website<\/a>.<\/p>\n About Medical Marijuana, Inc.<\/i><\/strong><\/p>\n Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company’s website at:\u00a0www.MedicalMarijuanaInc.com<\/a>.<\/p>\n About HempMeds<\/i><\/strong><\/p>\n HempMeds<\/a>\u2122\u00a0offers mainstream marketing, sales, customer service, and logistics for the cannabis industry.\u00a0HempMeds<\/a>\u2122\u00a0is a corporate portfolio company of\u00a0Medical Marijuana, Inc.<\/a>\u00a0(OTC Pink:MJNA) and the Company’s exclusive\u00a0master distributor and contracted marketing company. In addition to handling sales and distribution,\u00a0HempMeds<\/a>\u2122\u00a0is the communication hub for the Medical Marijuana Inc. portfolio of companies.<\/p>\n About Dixie Botanicals<\/i><\/strong><\/p>\n Regarded as one of the most well recognized brands in the industry, Dixie Botanicals\u2122 offers innovative hemp oil products for health conscious consumers. Our formulation experts include scientists, clinical herbalists and nutritionists who work to integrate our hemp oil into a variety of unique products. Dixie Botanicals’ products contain naturally occurring cannabidiol (CBD) hemp oil from the mature stalk of the industrial hemp plant. We test and analyze our products from seed to shelf, ensuring that every natural product we offer is free from contaminants and of the highest quality possible. (Click to view test results<\/a>.) For more information, visit: www.DixieBotanicals.com<\/a>.<\/p>\n About CanChew Biotechnologies<\/i><\/strong><\/p>\n CanChew Biotechnologies<\/a> focuses on the treatment of pain and other medical disorders with the application of cannabinoid medical products as well as food and nutraceutical products for general well-being.<\/p>\n The company is focused on the R&D and execution of their clinical development plan and potential out-licensing of their technology. Clinical development focuses on the R&D of the formulation, production and the development of chewing gum-based products for the treatment of conditions like pain, nausea and vomiting, anorexia, spasticity and various other medical issues. For more information on the company, visit CanChewGum.com<\/a>.<\/p>\n FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE<\/i><\/p>\n These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.<\/i><\/p>\n FORWARD-LOOKING DISCLAIMER<\/i><\/p>\n This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and\/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.<\/i><\/p>\n LEGAL DISCLOSURE<\/i><\/p>\n Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The Company does grow, sell and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.<\/i><\/p>\n \t<\/p>\n","protected":false},"excerpt":{"rendered":" Historic Vote by Senate Appropriations Committee Provides Veterans Access to Medical Cannabis in Legalized States; Texas Also Approves Limited Medical Marijuana Bill SAN DIEGO, May 22, 2015 (GLOBE NEWSWIRE) — Medical Marijuana, Inc. (OTC Pink:MJNA), a leading cannabis and industrial hemp industry innovator, applauds the historic decision by the U.S. Senate Appropriations Committee to provide […]<\/p>\n","protected":false},"author":1,"featured_media":1131,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[3,42,22,2],"tags":[270,184,167,49],"class_list":["post-3362","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company-news","category-dixie-botanicals","category-hempmeds","category-press-releases","tag-canchew-biotechnologies","tag-dixie-botanicals","tag-hempmeds","tag-medical-marijuana-inc"],"yoast_head":"\nCONTACT: For further information, please contact:\n \n Public Relations contact:\n Andrew Hard\n Spokesperson\n P. 858-380-5478\n andrew.hard@CMWmedia.com\n \n Corporate contact:\n Medical Marijuana, Inc.\n Toll Free: 888-OTC-MJNA (888-682-6562)\n www.medicalmarijuanainc.com<\/a>\n www.facebook.com\/mjnainc<\/a>\n \n Investor Relations:\n GH Investment Advisors\n 550 West \"C\" Street, Ste. 2040\n San Diego, CA 92101\n Nick Massalas\n Office: (858) 264-6500\n Toll Free: (877) 964-6463\n info@ghinvestmentadvisors.com<\/pre>\n